Skip to main content
. 2016 Mar 8;10:33. doi: 10.3389/fncel.2016.00033

Table 1.

Epidemiological data and status of medication for each group.

Control Group First episode patients Recurrent episode patients
Number (N) 22 11 6
Gender (male/female) 9/13 5/6 1/5
Age (years ± SD) 34.73 (±10.30) 30.53 (±9.95) 42.00 (±9.28)
Drug-naïve (number) 8 2
Drug-free (number, duration of drug-free period) 3 (5–14 days) 4 (4 days–5 months)
Previous medication Risperidone Risperidone, Olanzapine, Haloperidole